Inc., a global leader in nanotechnology, is pleased to announce the
launch of a Contract Research Program as part of its Nano BioDiscovery
Division. Based on the patented Dip Pen Nanolithography (DPN) platform,
NanoInk's contract services provide miniaturization and multiplex protein analysis.
Drawing on NanoInk's expertise in array fabrication and protein analysis, the
new contract research program includes a wide range of protein array services.
Customers can choose from complete custom assay development and analysis projects
to protein profiling work, to custom array printing.
Bruce Dudzik, NanoInk's Senior Director for Business Development, explained
that the typical NanoInk Nano BioDiscovery assay development project begins
with the client specifying proteins of interest. "Working in close consultation
with the customer at each step of the process, NanoInk's dedicated Contract
Research scientists then develop the custom assay protocol, fabricate the custom
nanoarrays, conduct on-array assays, extract and analyze data, and develop a
comprehensive final report that includes image files and raw data."
DPN technology is capable of depositing highly reproducible, submicron protein
features in one sub-array and patterning as many as 96 sub-arrays per slide.
As a result, NanoInk's Nano BioDiscovery protein array services deliver unmatched
assay sensitivity, even with the smallest of sample sizes. Just as importantly,
nanoscale protein arrays enable multi-parallel, high throughput analysis.
The Nano BioDiscovery Division provides a new era of array-based instrument
systems and contract research services for nanoscale protein detection. By combing
DPN nanofabrication technology with optimized substrates and next-generation
detection systems for a total system solution, Nano BioDiscovery helps its customers
address major proteomic challenges.
Please visit http://www.nanoink.net/NanoBio_about.htm
or call (847) 679-3432 for more information on the Nano BioDiscovery Division
and its Contract Research Program.